<DOC>
	<DOC>NCT00004480</DOC>
	<brief_summary>OBJECTIVES: I. Determine the optimal dose of botulinum toxin necessary to decrease sweating in patients with primary hyperhidrosis.</brief_summary>
	<brief_title>Study of Botulinum Toxin in Patients With Primary Hyperhidrosis</brief_title>
	<detailed_description>PROTOCOL OUTLINE: Patients receive injections of botulinum toxin in the clinical trial for 6 months. Patients undergo an iodine starch test and a sympathetic skin response test to assess the efficacy of the drug. Patients also complete questionnaires to evaluate the amount of sweating.</detailed_description>
	<mesh_term>Hyperhidrosis</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Diagnosis of hyperhidrosis Excessive sweating in the hands, feet, armpits, forehead, or body</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2004</verification_date>
	<keyword>dermatologic disorders</keyword>
	<keyword>hyperhidrosis</keyword>
	<keyword>rare disease</keyword>
</DOC>